Segui
Péter Fülöp
Péter Fülöp
Associate professor, Dept. of Internal Medicine, University of Debrecen
Email verificata su belklinika.com
Titolo
Citata da
Citata da
Anno
Uncoupling protein‐2 deficiency promotes oxidant stress and delays liver regeneration in mice
M Horimoto, P Fülöp, Z Derdák, JR Wands, G Baffy
Hepatology 39 (2), 386-392, 2004
1432004
Enhanced colon tumor induction in uncoupling protein-2 deficient mice is associated with NF-κB activation and oxidative stress
Z Derdák, P Fülöp, E Sabo, R Tavares, EP Berthiaume, MB Resnick, ...
Carcinogenesis 27 (5), 956-961, 2006
912006
Association of chemerin with oxidative stress, inflammation and classical adipokines in non‐diabetic obese patients
P Fülöp, I Seres, H Lőrincz, M Harangi, S Somodi, G Paragh
Journal of cellular and molecular medicine 18 (7), 1313-1320, 2014
842014
Lack of UCP2 reduces fas‐mediated liver injury in ob/ob mice and reveals importance of cell‐specific UCP2 expression
P Fülöp, Z Derdák, A Sheets, E Sabo, EP Berthiaume, MB Resnick, ...
Hepatology 44 (3), 592-601, 2006
742006
High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus
K Gaál, T Tarr, H Lőrincz, V Borbás, I Seres, M Harangi, P Fülöp, ...
Lipids in health and disease 15, 1-8, 2016
542016
Orlistat increases serum paraoxonase activity in obese patients
M Audikovszky, G Pados, I Seres, M Harangi, P Fülöp, E Katona, L Illyés, ...
Nutrition, metabolism and cardiovascular diseases 17 (4), 268-273, 2007
502007
HMG CoA reductase inhibitor fluvastatin arrests the development of implanted hepatocarcinoma in rats.
G Paragh, P Kertai, P Kovacs, G Paragh Jr, P Fülöp, G Foris
Anticancer research 23 (5A), 3949-3954, 2003
502003
Strong correlations between circulating chemerin levels and lipoprotein subfractions in nondiabetic obese and nonobese subjects
H Lőrincz, M Katkó, M Harangi, S Somodi, K Gaál, P Fülöp, G Paragh, ...
Clinical endocrinology 81 (3), 370-377, 2014
452014
Dynamic interplay between metabolic syndrome and immunity
G Paragh, I Seres, M Harangi, P Fülöp
Oxidative Stress and Inflammation in Non-communicable Diseases-Molecular …, 2014
422014
Different anticancer effects of fluvastatin on primary hepatocellular tumors and metastases in rats
G Paragh, G Fóris, G Paragh Jr, I Seres, Z Karányi, P Fülöp, Z Balogh, ...
Cancer letters 222 (1), 17-22, 2005
352005
Paraoxonase-1 and adipokines: potential links between obesity and atherosclerosis
P Fülöp, M Harangi, I Seres, G Paragh
Chemico-biological interactions 259, 388-393, 2016
332016
Plasminogen activator inhibitor-1 level correlates with lipoprotein subfractions in obese nondiabetic subjects
S Somodi, I Seres, H Lőrincz, M Harangi, P Fülöp, G Paragh
International Journal of Endocrinology 2018, 2018
312018
Effects of simvastatin on serum paraoxonase activity
Z Balogh, P Fülöp, I Seres, M Harangi, E Katona, P Kovacs, B Kosztáczky, ...
Clinical Drug Investigation 21, 505-510, 2001
222001
The effect of low-intensity aerobic training on cognitive functions of severely deconditioned subacute and chronic stroke patients: a randomized, controlled pilot study
A Debreceni-Nagy, J Horváth, NB Kovács, P Fülöp, Z Jenei
International Journal of Rehabilitation Research 42 (3), 275-279, 2019
212019
The association between angiotensin II-induced free radical generation and membrane fluidity in neutrophils of patients with metabolic syndrome
I Seres, G Foris, Z Varga, B Kosztaczky, A Kassai, Z Balogh, P Fülöp, ...
The Journal of membrane biology 214, 91-98, 2006
172006
Changes in triglyceride, HDL-C, and non-HDL-C levels in patients with acute coronary syndrome
P Koncsos, P Fülöp, I Juhász, K Bíró, L Márk, G Simonyi, G Paragh
Wiener Klinische Wochenschrift 128, 858-863, 2016
162016
Paraoxonase-1 arylesterase activity is an independent predictor of myeloperoxidase levels in overweight patients with or without cardiovascular complications
N Zsíros, P Koncsos, H Lőrincz, I Seres, M Katkó, A Szentpéteri, VE Varga, ...
Clinical biochemistry 49 (12), 862-867, 2016
162016
Identifying patients with familial hypercholesterolemia using data mining methods in the Northern Great Plain region of Hungary
G Paragh, M Harangi, Z Karányi, B Daróczy, Á Németh, P Fülöp
Atherosclerosis 277, 262-266, 2018
152018
Increased hair selenium concentration in hyperlipidemic patients
P Fülöp, I Seres, Z Jenei, I Juhász, G Paragh
Journal of Cellular and Molecular Medicine 17 (3), 350-355, 2013
122013
Causes, clinical findings and therapeutic options in chylomicronemia syndrome, a special form of hypertriglyceridemia
G Paragh, Á Németh, M Harangi, M Banach, P Fülöp
Lipids in Health and Disease 21 (1), 1-14, 2022
112022
Il sistema al momento non puň eseguire l'operazione. Riprova piů tardi.
Articoli 1–20